- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in drugmakers
Drugmakers To Price Hike At Least 350 Drugs In Us In January
The increases are expected to come as the pharmaceutical industry prepares for the Biden Administration's Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices directly for some drugs starting in 2026
Read More
Sun Pharma, Lupin Recall Products In US Market, Says USFDA
New Jersey-based Sun Pharmaceutical Industries Inc, a unit of the company, has initiated the Class III nationwide (US) recall of the 10-count blister packs on October 12 this year.
Read More
Insurers, Drugmakers Sail Into Unknown With COVID Vaccine Rollout
Pharmaceutical companies normally manage the risks of transporting their products through buying insurance or relying on an in-house insurer, known as a "captive" insurer.
Read More
Pfizer-BioNTech Vaccine Deliveries Could Start 'Before Christmas'
Global shares rose as the trial results countered concerns around the soaring infection rate. Pfizer shares were up 1.6% while BioNTech jumped 3.8% in the United States. Moderna shares fell 3.6%.
Read More
Takeda-Led COVID-19 Plasma Treatment Enters Clinical Trial With First Patient
The phase 3 trial by the group, known as the CoVIg Plasma Alliance, aims to enroll 500 adult patients from the United States, Mexico and 16 other countries
Read More
Gilead To Pay $97 Million To Settle U.S. Kickback Probe
Gilead's actions enabled the Foster City, California-based drugmaker to boost revenue, ran from June 2007 to December 2010, and violated the federal False Claims Act, the department said.
Read More
Vaccine Makers Including Moderna Must Hit US Timing Goals For Full Payments
Moderna also receives $600 million when it can demonstrate it has built out industrial-scale manufacturing capabilities for its vaccine, even if that happens before the drug is authorized by regulators, the filings show.
Read More
Next Big COVID-19 Treatment May Be Manufactured Antibodies
Scientists are still working out the exact role of neutralizing antibodies in recovery from COVID-19, but drugmakers are confident that the right antibodies or a combination can alter the course of the disease that has claimed more than 675,000 lives globally.
Read More
Cadila Aims To Complete Trial Of Coronavirus Vaccine By March
Cadila's vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic.
Read More
Novartis Pays $729 Million To Settle US Kickback Charges
The $678 million payout includes $591.4 million in damages to the U.S. government, a $38.4 million forfeiture for violating an anti-kickback statute and $48.2 million to U.S. states.
Read More
Inovio Gets $71 Million From U.S. Defense Dept For COVID-19 Vaccine Device
Inovio said a previous version of the device has been used in clinical trials to safely dose more than 2,000 patients
Read More
Lilly, Junshi Biosciences Plan To Start Human Trials Of COVID-19 Antibody In Q2
Lilly and several other drugmakers such as Gilead Sciences, Pfizer Inc and Merck & Co Inc are racing to develop treatments or vaccines for the fast-spreading respiratory illness caused by the novel coronavirus.
Read More
Moderna, Switzerland's Lonza Strike Deal On Potential COVID-19 Vaccine
Moderna got a $483 million funding from a U.S. government agency to accelerate its COVID-19 vaccine development.
Read More
Dr Reddy's Fourth-quarter Profit Falls 19% On US Headwinds
Revenue from the generics business in North America, its biggest market, dropped 6 percent to Rs 14.49 billion due to price erosions and increased competition
Read More
Branching Out
Lately, the pharma sector in India is focusing on OTC products besides working on its usual fare. A move that could be win-win for both businesses and consumers
Read More